Statistical Evaluation of Mutagenicity Test Data PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Statistical Evaluation of Mutagenicity Test Data PDF full book. Access full book title Statistical Evaluation of Mutagenicity Test Data by David J. Kirkland. Download full books in PDF and EPUB format.
Author: David J. Kirkland
Publisher: Cambridge University Press
ISBN: 9780521048149
Category : Medical
Languages : en
Pages : 316
Get Book
Book Description
This rigorous and practical account of the interpretation of mutagenicity test data draws upon the expertise of toxicologists and statisticians. Chemicals, such as drugs, food additives and pesticides, all need careful screening to eliminate potentially mutagenic compounds.
Author: David J. Kirkland
Publisher: Cambridge University Press
ISBN: 9780521048149
Category : Medical
Languages : en
Pages : 316
Get Book
Book Description
This rigorous and practical account of the interpretation of mutagenicity test data draws upon the expertise of toxicologists and statisticians. Chemicals, such as drugs, food additives and pesticides, all need careful screening to eliminate potentially mutagenic compounds.
Author:
Publisher:
ISBN:
Category : Mutagenicity testing
Languages : en
Pages : 294
Get Book
Book Description
Author: Ludwig Hothorn
Publisher: Springer Science & Business Media
ISBN: 364248736X
Category : Medical
Languages : en
Pages : 158
Get Book
Book Description
This book contains selected papers from a workshop on modern statistical methods in toxicology held during the EUROTOX '90 conference in Leipzig. The papers deal with the biostatistical evaluation of the commonly used toxicological assays, i.e. mutagenicity, long-term carcinogenicity, embryotoxicity and chronic toxicity assays. The biological background is considered in detail, and most of the related statistical approaches described. In five overview papers, the present state of the art of the related topics is given, while in several contributed papers new approaches are discussed. The most important features are: - A new view on the per-litter analysis problem in em- bryotoxicity assays. - A highly sophisticated treatment of the so-called muta-tox problem in mutagenicity assays. - A detailed discussion of the multiplicity problem based on the closed testing procedure. This volume provides readers with an overview of modern biostatistical methods for several toxicological assays and is in part intended for direct, practical use.
Author: David J. Kirkland
Publisher: Cambridge University Press
ISBN: 9780521393478
Category : Medical
Languages : en
Pages : 164
Get Book
Book Description
A summary of the essential texts that must be performed on all new compounds before they can be registered for use in the UK.
Author: Byron J. T. Morgan
Publisher: Oxford University Press
ISBN: 9780198523291
Category : Mathematics
Languages : en
Pages : 250
Get Book
Book Description
This collection of papers on aspects of statistics in toxicology is will be of interest to all medical statisticians. It offers findings from numerous leading experts from around the world including A. Whitehead and R. N. Connor (University of Reading), L. Ryan (Harvard), A. P. Grieve (Pfizer Research), K.J. Risko (Northern Telecom), and B.H. Margolin (University of North Carolina). This is the latest in the popular Royal Statistical Society Lecture Series, and will be essential reading for all those involved in this area.
Author: Shayne Cox Gad
Publisher: John Wiley & Sons
ISBN: 1119097401
Category : Medical
Languages : en
Pages : 918
Get Book
Book Description
This practical guide presents a road map for safety assessment as an integral part of the development of new drugs and therapeutics. Helps readers solve scientific, technical, and regulatory issues in preclinical safety assessment and early clinical drug development Explains scientific and philosophical bases for evaluation of specific concerns – including local tissue tolerance, target organ toxicity and carcinogenicity, developmental toxicity, immunogenicity, and immunotoxicity Covers the development of new small and large molecules, generics, 505(b)(2) route NDAs, and biosimilars Revises material to reflect new drug products (small synthetic, large proteins and cells, and tissues), harmonized global and national regulations, and new technologies for safety evaluation Adds almost 20% new and thoroughly updates existing content from the last edition
Author: United Kingdom Environmental Mutagen Society. Sub-Committee on Guidelines for Mutagenicity Testing
Publisher: Cambridge University Press
ISBN: 052145073X
Category : Medical
Languages : en
Pages : 179
Get Book
Book Description
Originally published in 1993, this volume describes supplementary tests used to assess risks of in vitro mutagenicity when basic safety tests were inconclusive.
Author: Shein-Chung Chow
Publisher: CRC Press
ISBN: 1351110268
Category : Medical
Languages : en
Pages : 2434
Get Book
Book Description
Since the publication of the first edition in 2000, there has been an explosive growth of literature in biopharmaceutical research and development of new medicines. This encyclopedia (1) provides a comprehensive and unified presentation of designs and analyses used at different stages of the drug development process, (2) gives a well-balanced summary of current regulatory requirements, and (3) describes recently developed statistical methods in the pharmaceutical sciences. Features of the Fourth Edition: 1. 78 new and revised entries have been added for a total of 308 chapters and a fourth volume has been added to encompass the increased number of chapters. 2. Revised and updated entries reflect changes and recent developments in regulatory requirements for the drug review/approval process and statistical designs and methodologies. 3. Additional topics include multiple-stage adaptive trial design in clinical research, translational medicine, design and analysis of biosimilar drug development, big data analytics, and real world evidence for clinical research and development. 4. A table of contents organized by stages of biopharmaceutical development provides easy access to relevant topics. About the Editor: Shein-Chung Chow, Ph.D. is currently an Associate Director, Office of Biostatistics, U.S. Food and Drug Administration (FDA). Dr. Chow is an Adjunct Professor at Duke University School of Medicine, as well as Adjunct Professor at Duke-NUS, Singapore and North Carolina State University. Dr. Chow is the Editor-in-Chief of the Journal of Biopharmaceutical Statistics and the Chapman & Hall/CRC Biostatistics Book Series and the author of 28 books and over 300 methodology papers. He was elected Fellow of the American Statistical Association in 1995.
Author:
Publisher:
ISBN:
Category : Biometry
Languages : en
Pages : 320
Get Book
Book Description
Author: Shayne C. Gad
Publisher: Wiley-Interscience
ISBN:
Category : Medical
Languages : en
Pages : 1056
Get Book
Book Description
Covers the scientific and philosophical bases for evaluation of specific concerns, such as carcinogenicity and development toxicity.
